Write For Us

Novo valuation beats Tesla on experimental obesity drug data | REUTERS

Sponsored Post Vitamin D2 Canada Persia
9 Views
Published
Novo Nordisk surpassed Tesla in market valuation after the maker of the popular weight-loss drug Wegovy announced positive early trial data for a highly anticipated new obesity drug.

#News #Reuters #Newsfeed #novonordisk #wegovy #tesla #weightloss

Read the story here: https://reut.rs/49HqfmB

???? Subscribe: http://smarturl.it/reuterssubscribe

Keep up with the latest news from around the world: https://www.reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en
Category
World
Tags
reuters, news, world news today
Sign in or sign up to post comments.
Be the first to comment